Cargando…
Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787004/ https://www.ncbi.nlm.nih.gov/pubmed/35129544 http://dx.doi.org/10.1007/s13691-021-00517-8 |
_version_ | 1784639265278263296 |
---|---|
author | Furune, Satoshi Kondo, Chiaki Takano, Yuko Shimokata, Tomoya Sugishita, Mihoko Mitsuma, Ayako Maeda, Osamu Ando, Yuichi |
author_facet | Furune, Satoshi Kondo, Chiaki Takano, Yuko Shimokata, Tomoya Sugishita, Mihoko Mitsuma, Ayako Maeda, Osamu Ando, Yuichi |
author_sort | Furune, Satoshi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8787004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-87870042022-02-02 Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment Furune, Satoshi Kondo, Chiaki Takano, Yuko Shimokata, Tomoya Sugishita, Mihoko Mitsuma, Ayako Maeda, Osamu Ando, Yuichi Int Cancer Conf J Correction Springer Singapore 2021-10-26 /pmc/articles/PMC8787004/ /pubmed/35129544 http://dx.doi.org/10.1007/s13691-021-00517-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Furune, Satoshi Kondo, Chiaki Takano, Yuko Shimokata, Tomoya Sugishita, Mihoko Mitsuma, Ayako Maeda, Osamu Ando, Yuichi Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title | Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title_full | Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title_fullStr | Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title_full_unstemmed | Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title_short | Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
title_sort | correction to: vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787004/ https://www.ncbi.nlm.nih.gov/pubmed/35129544 http://dx.doi.org/10.1007/s13691-021-00517-8 |
work_keys_str_mv | AT furunesatoshi correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT kondochiaki correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT takanoyuko correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT shimokatatomoya correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT sugishitamihoko correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT mitsumaayako correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT maedaosamu correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment AT andoyuichi correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment |